Prenatal Opioid Exposure, Neonatal Abstinence Syndrome/Neonatal Opioid Withdrawal Syndrome, and Later Child

Hendrée E Jones1, Karol Kaltenbach, Tara Benjamin

  • 1UNC Horizons and Department of Obstetrics and Gynecology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC (HEJ); Departments of Psychiatry and Obstetrics and Gynecology, School of Medicine, Johns Hopkins University, Baltimore, MD (HEJ); Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA (KK); Department of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine, Indiana University School of Medicine, Indianapolis, IN (TB); Department of Pediatrics, Boston Medical Center, Boston, MA (EMW); Department of Psychology, University of Maryland, College Park, College Park, MD (KEO'G).

Insights

Research on Neonatal Abstinence Syndrome (NAS) and child development has limitations. This paper addresses these shortcomings, proposing solutions and an alternative framework for understanding developmental outcomes in children exposed to opioids.

Area of Science:

  • Pediatrics
  • Developmental Psychology
  • Public Health

Background:

  • The opioid epidemic has increased focus on Neonatal Abstinence Syndrome (NAS).
  • Concerns exist regarding the long-term effects of NAS on child development.
  • Current research faces methodological challenges in linking NAS to developmental outcomes.

Purpose of the Study:

  • Critique existing research on NAS and child development.
  • Propose methodological improvements for NAS research.
  • Recommend an alternative framework for understanding developmental issues in children with prenatal opioid exposure.

Main Methods:

  • Analysis of research methodologies in NAS and child development studies.
  • Identification of shortcomings in population definitions, comparison groups, matching, and statistical analyses.
  • Discussion of the implicit single-cause fallacy in NAS research.

Main Results:

  • Current research on NAS and child development suffers from definitional, comparative, and analytical limitations.
  • A single-cause fallacy often overlooks complex contributing factors.
  • Over-reliance on NAS diagnosis can lead to harm and missed opportunities for comprehensive support.

Conclusions:

  • Methodological rigor is crucial for accurate understanding of NAS long-term effects.
  • An alternative framework is needed to account for multifactorial influences on child development.
  • Addressing the complexities of interpersonal, intrapersonal, and environmental factors is essential for supporting children's developmental trajectories.

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.1K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
4.3K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.0K
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
676
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
636
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
994